Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
12 sept. 2023 16h05 HE
|
Exagen Inc.
SAN DIEGO, California, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2023 Cantor...
Exagen Inc. Reports Strong Second Quarter 2023 Results
07 août 2023 08h00 HE
|
Exagen Inc.
SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended June 30, 2023. ...
Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference
26 juil. 2023 16h05 HE
|
Exagen Inc.
SAN DIEGO, July 26, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Canaccord Genuity 43rd Annual...
Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023
25 juil. 2023 16h05 HE
|
Exagen Inc.
SAN DIEGO, July 25, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended June 30, 2023, before...
Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference
30 mai 2023 09h00 HE
|
Exagen Inc.
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the William Blair 43rd Annual Growth...
Exagen Inc. Reports First Quarter 2023 Results
15 mai 2023 16h05 HE
|
Exagen Inc.
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN)("Exagen"), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31,...
Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023
24 avr. 2023 16h05 HE
|
Exagen Inc.
SAN DIEGO, April 24, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended March 31, 2023,...
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
06 mars 2023 16h05 HE
|
Exagen Inc.
SAN DIEGO, March 06, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter and year ended December...
Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
30 janv. 2023 16h05 HE
|
Exagen Inc.
SAN DIEGO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the BTIG MedTech, Digital Health,...
Exagen Inc. Reports Third Quarter 2022 Results
14 nov. 2022 16h05 HE
|
Exagen Inc.
SAN DIEGO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2022....